Predictive factors for the success of trial without catheter for men with urinary retention
ConclusionsThis is the first study classifying patients with urinary retention according to medication status. Both medicated and na ïve groups had different patient backgrounds and TWOC outcome predictors, suggesting a discrepant etiology behind urinary retention. Hence, acute urinary retention management in men should vary based on medication status for male lower urinary tract symptoms when urinary retention is diagnosed. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - June 6, 2023 Category: Urology & Nephrology Authors: Masato Takanashi, Hiroki Ito, Takeshi Fukazawa, Hiroki Takizawa, Mari Hioki, Risa Shinoki, Takashi Kawahara, Kazuki Kobayashi Tags: ORIGINAL ARTICLE Source Type: research

Risk factors for a failed trial without catheter following convective water vapor thermal therapy (CWVTT ‐Rezum)
ConclusionsSeventeen percent of patients failed their initial TWOC after CWVTT. Elevated postvoid residual was associated with TWOC failure. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - May 27, 2023 Category: Urology & Nephrology Authors: Michael D. Felice, Kaylin Kim, Sarang Janakiraman, Gaurav Pahouja, William Adams, Erin Fruth, Ahmer Farooq, Kevin T. McVary Tags: ORIGINAL ARTICLE Source Type: research

Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms —A randomized controlled trial
ConclusionsOur study showed that mirabegron is equally effective as solifenacin in treating Sjogren's syndrome patients with overactive bladder. Mirabegron is superior to solifenacin in terms of treatment-related adverse events. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - May 17, 2023 Category: Urology & Nephrology Authors: Hao Xiang Chen, Shih ‐Hsin Chang, Der‐Yuan Chen, Joung‐Liang Lan, Kai‐Jieh Yeo, Po‐Hao Huang, Chung‐Ming Huang, Chi‐Ping Huang, Eric Chieh‐Lung Chou, Po‐Chang Wu Tags: ORIGINAL ARTICLE Source Type: research

Efficacy and safety of the Rezum system for the treatment of catheter ‐dependent urinary retention: Three‐year real‐world outcomes in a multimorbid, multiethnic population
ConclusionsAt long-term follow-up, Rezum effectively treated catheter-dependent urinary retention with minimal decisional regret. In patients with urinary retention, urologists should consider delaying TOV until 2  weeks postoperatively to maximize the likelihood of a successful TOV and minimize the risk of AEs. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - May 16, 2023 Category: Urology & Nephrology Authors: Mustufa Babar, Zaki Masoud, Kevin Labagnara, Justin Loloi, Rahman Sayed, Sandeep Singh, Kevin Tang, Umar Syed, Michael Ciatto Tags: ORIGINAL ARTICLE Source Type: research

Mirabegron versus vibegron in previously untreated female patients with overactive bladder: A randomized, single ‐clinic, open‐label trial
ConclusionsThese results showed that both drugs were effective in female OAB patients, with no significant differences in terms of efficacy. However, the safety of vibegron requires further investigation. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - May 5, 2023 Category: Urology & Nephrology Authors: Hirotaka Sato, Shota Otsuka, Sachiyuki Tsukada Tags: ORIGINAL ARTICLE Source Type: research

Issue Information
(Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - April 27, 2023 Category: Urology & Nephrology Tags: ISSUE INFORMATION Source Type: research

The efficacy of antibiotic and alpha ‐blocker combination therapy versus antibiotic monotherapy in chronic prostatitis/chronic pelvic pain syndrome: A systematic review
ConclusionsThe combination therapy of antibiotics and alpha-blockers is not substantially better than antibiotic monotherapy in the first 6  weeks of treatment for CP/CPPS patients. This might not be applicable to a longer duration of treatment. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - April 3, 2023 Category: Urology & Nephrology Authors: Fina Widia, Widi Atmoko, Natanael Parningotan Agung, Harrina Erlianti Rahardjo, Nur Rasyid, Ponco Birowo, Akmal Taher Tags: ORIGINAL ARTICLE Source Type: research

Lower urinary tract symptoms are elevated with depression in Japanese women
ConclusionsThis study revealed that worsening of LUTS was correlated with depression. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - March 31, 2023 Category: Urology & Nephrology Authors: Sahoko Ninomiya, Takashi Kawahara, Sohgo Tsutsumi, Hiroki Ito, Kazuhide Makiyama, Hiroji Uemura Tags: ORIGINAL ARTICLE Source Type: research

Anatomic outcomes of sacrohysteropexy without posterior mesh placement in patients with asymptomatic grade 1 and 2 rectoceles: Is a rectouterine mesh really necessary?
ConclusionsSacrohysteropexy without posterior mesh placement might be associated with less pain, shorter operative time, and shorter recovery time of gastrointestinal motility, without compromising the anatomic success. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - March 30, 2023 Category: Urology & Nephrology Authors: Adem Sanc ı, Khaled Obaid, Murat Topcuoglu, Mehmet İlker Gokce, Evren Süer, Ömer Gülpinar Tags: ORIGINAL ARTICLE Source Type: research

TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients
ConclusionsIn postmenopausal women with MUI, TOT-P demonstrated the same effectiveness as TOT-S in reducing urinary symptoms. In addition, TOT-P increased VHI and sexual function scores compared with TOT-S. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - March 5, 2023 Category: Urology & Nephrology Authors: Federica Sala, Melania Loggia, Giorgia Cardella, Claudia Morgani, Giovanni Grossi, Marzio Angelo Zullo, Herbert Carmelo Carlo Valensise, Pier Luigi Palazzetti, Michele Carlo Schiavi Tags: ORIGINAL ARTICLE Source Type: research

Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta ‐analysis
ConclusionsBoth drugs seem to be comparable and well tolerated, particularly as direct comparisons are not available. However, vibegron may be more effective than mirabegron in reducing mean voided volume. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - March 3, 2023 Category: Urology & Nephrology Authors: Wenjuan He, Yuqian Zhang, Guangliang Huang, Yunfei Tian, Qian Sun, Xiuju Liu Tags: ORIGINAL ARTICLE Source Type: research

Issue Information
(Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - March 1, 2023 Category: Urology & Nephrology Tags: ISSUE INFORMATION Source Type: research

Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50  μg
ConclusionsOur study suggests that an initial dose of 50  μg is more effective than a uniformly minimum dose based on factors such as age and physique. Furthermore, a high continuation rate can be achieved by appropriately reducing the dose, if adverse events occur. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - February 9, 2023 Category: Urology & Nephrology Authors: Hirofumi Kurose, Keisuke Komiya, Naoyuki Ogasawara, Kosuke Ueda, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Mitsunori Matsuo, Shigetaka Suekane, Tsukasa Igawa Tags: ORIGINAL ARTICLE Source Type: research

Does histological prostatic inflammation during transurethral resection of the prostate for bladder outlet obstruction affect post ‐operative urinary outcomes?
ConclusionHistological prostatitis is associated with worse urinary outcomes after TURP compared to no inflammation. These results are useful in improving prognostic discussions with patients after TURP. (Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - January 24, 2023 Category: Urology & Nephrology Authors: Bharti Arora, Munad Khan, Simon Pridgeon Tags: ORIGINAL ARTICLE Source Type: research

Issue Information
(Source: LUTS: Lower Urinary Tract Symptoms)
Source: LUTS: Lower Urinary Tract Symptoms - January 3, 2023 Category: Urology & Nephrology Tags: ISSUE INFORMATION Source Type: research